Sino BiopharmaceuticalSBMFF -4.96%61 Days Payable is 148.12 as of Dec. 2025, which is 28% above its 10-year median of 115.88. GuruFocus rates SBMFF with a GF Score™ of 61/100 and a GF Value™ of $0.65 (Fairly Valued). The stock has 4 warning signs investors should review. Among 704 Biotechnology companies, Sino Biopharmaceutical ranks better than 52.41% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SBMFF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Sino Biopharmaceutical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sino Biopharmaceutical Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Days Payable distribution charts can be found below:
* The bar in red indicates where Sino Biopharmaceutical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sino Biopharmaceutical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sino Biopharmaceutical (SBMFF) has a Days Payable of 148.12 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sino Biopharmaceutical and its competitors. This is 28% above median its historical median of 115.88. Over the past decade, Sino Biopharmaceutical's Days Payable has ranged from 94.15 to 142.09. According to the industry distribution chart, Sino Biopharmaceutical ranks #335 out of 704 companies in the Biotechnology industry, placing it in the top 47.6%.
Is Sino Biopharmaceutical's Days Payable too high?
Sino Biopharmaceutical's current Days Payable of 148.12 is 28% above median its 10-year median of 115.88. Over the past 10 years, this metric has ranged from a low of 94.15 to a high of 142.09. The Biotechnology industry median Days Payable is 113.56. Sino Biopharmaceutical's value of 148.12 is 30.4% above this industry median. Based on the distribution chart, Sino Biopharmaceutical ranks #335 out of 704 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sino Biopharmaceutical has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sino Biopharmaceutical's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sino Biopharmaceutical ranks #335 out of 704 companies for Days Payable. This puts Sino Biopharmaceutical in the upper half of its industry. The industry median Days Payable is 113.56. Sino Biopharmaceutical's value of 148.12 is 30.4% above this benchmark. Historically, Sino Biopharmaceutical's own Days Payable has ranged from 94.15 to 142.09 over the past decade. While the company's 10-year median is 115.88 vs. the industry median of 113.56, Sino Biopharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sino Biopharmaceutical's current Days Payable of 148.12 is 30.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sino Biopharmaceutical and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sino Biopharmaceutical's current Days Payable is 148.12, which is 28% above median its own 10-year median of 115.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sino Biopharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Sino Biopharmaceutical (SBMFF) is currently considered Fairly Valued. The stock's GF Value™ is $0.65, compared to a current price of $0.60 — trading 7.4% below its estimated fair value. The current Days Payable is 148.12, which is 28% above median its 10-year median of 115.88 and 30.4% above the Biotechnology industry median of 113.56. Sino Biopharmaceutical's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sino Biopharmaceutical (SBMFF), the current Days Payable is 148.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sino Biopharmaceutical (SBMFF) Overvalued in 2026?
Based on GuruFocus' analysis, Sino Biopharmaceutical stock appears to be undervalued.
The current stock price of $0.60 is trading 7.4% below its estimated GF Value™ of $0.65.
GuruFocus considers Sino Biopharmaceutical to be Fairly Valued.
Key valuation signals for SBMFF:
Days Payable: 148.12 (28% above median its 10-year median of 115.88)
GF Value™: $0.65 vs. price of $0.60 (7.4% below fair value)
Industry Position: 30.4% above the Biotechnology median (#335 of 704)
No single metric tells the full story. See the SBMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sino Biopharmaceutical Ltd is an investment holding company. The company and its subsidiaries are principally engaged in the research and development, production and sale of a series of pharmaceutical products. Its business covering the entire industrial chain of R&D, production and commercialization of drugs, biological products and high-end generic drugs. The company's therapeutic areas include: oncology, liver disease, respiratory, and surgery/pain relief. The company's revenue was generated from the sale of pharmaceutical products in the Chinese mainland.
61GF Score
Get the complete analysis for SBMFF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBMFF has been successfully added to your 
